Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Targeted Anti-cancer Therapies (TAT) conference roundup

Share :
Published: 22 Apr 2014
Views: 2554
Rating:
Save
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

Prof Gordon McVie of ecancer and European Institute of Oncology, Milan, Italy gives a roundup of the 12th International Congress on Targeted Anti-cancer Therapies (TAT) conference.

Related Videos

Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Dr Elias Mai - Heidelberg University, Heidelberg, Germany
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM ( Dr Elias Mai - Heidelberg University, Heidelberg, Germany )
28 Oct 2024
Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies
Prof Philippe Moreau - University Hospital of Nantes, Nantes, France
Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies ( Prof Philippe Moreau - University Hospital of Nantes, Nantes, France )
30 Sep 2024
ESMO 2024: Highlights and analysis
Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2024: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
16 Sep 2024
Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse...
Dr Jeremy Abramson - Mass General Cancer Center, Boston, USA
Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lymphoma ( Dr Jeremy Abramson - Mass General Cancer Center, Boston, USA )
9 Jul 2024
TP53 mutations are linked to unfavourable prognosis in chronic lymphocytic...
Dr Consuelo Bertossi - University Hospital of Ulm, Ulm, Germany
TP53 mutations are linked to unfavourable prognosis in chronic lymphocytic leukaemia ( Dr Consuelo Bertossi - University Hospital of Ulm, Ulm, Germany )
27 Jun 2024
ASCO 2024: Lung cancer highlights
Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas...
ASCO 2024: Lung cancer highlights ( Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas Girard and Dr Anna Minchom )
26 Jun 2024
EHA 2024: Multiple myeloma roundup
Dr Claudio Cerchione - IRCCS, Meldola, Italy
EHA 2024: Multiple myeloma roundup ( Dr Claudio Cerchione - IRCCS, Meldola, Italy )
26 Jun 2024
Belantamab mafodotin, pomalidomide and dexamethasone shows superior efficacy in...
Prof Meletios Dimopoulos - University of Athens, Athens, Greece
Belantamab mafodotin, pomalidomide and dexamethasone shows superior efficacy in RRMM compared to standard of care in 2nd line ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )
24 Jun 2024
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale...
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )
25 Mar 2024

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation